No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Chemoradiotherapy with carboplatin is more effective than cetuximab in head and neck squamous cell carcinoma

byTeddy Guo

October 18, 2022

in StudyGraphics

Reading Time: 1 min read

Click to read this study in JAMA Otolaryngology – Head & Neck Surgery.

RELATED REPORTS

Pembrolizumab improves survival in locally advanced head and neck cancer

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

Greater thoracic aortic aneurysm size associated with worse long-term outcomes

RelatedReports

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Oncology

Pembrolizumab improves survival in locally advanced head and neck cancer

August 26, 2025

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Chronic Disease

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

July 24, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembroli-zumab Increased Survival in Locally Advanced Head and Neck Cancer

July 18, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes associated with reduced atrial fibrillation hospitalization events compared to commonly used comparators

Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout

#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result